[Hub]/) : Traits : Cholesterol lowering medication : ← →

chr9:135,883,620-136,399,075

Best TWAS P=1.13e-09 · Best GWAS P=1.31e-09 conditioned to 0.00566

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
9	The Cancer Genome Atlas	Rectum Adenocarcinoma	ABO	0.48	0.23	enet	10	0.27	4.7e-07	5.7	6.1	1.1e-09	0.65	0.00	0.98	TRUE
5	The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	ABO	0.23	0.23	lasso	2	0.24	2.2e-11	5.5	5.5	2.9e-08	0.53	0.00	1.00	FALSE
8	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	ABO	0.23	0.23	lasso	3	0.23	2.0e-09	5.2	5.3	1.4e-07	0.61	0.00	0.99	FALSE
7	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	ABO	0.28	0.22	lasso	8	0.22	1.2e-14	5.2	5.3	1.5e-07	0.63	0.01	0.99	FALSE
3	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	ABO	0.31	0.38	lasso	5	0.42	3.1e-26	5.5	5.2	1.6e-07	0.54	0.00	1.00	FALSE
6	The Cancer Genome Atlas	Lung Adenocarcinoma	ABO	0.21	0.25	lasso	5	0.25	2.1e-29	5.2	5.2	1.6e-07	0.59	0.01	0.99	FALSE
4	The Cancer Genome Atlas	Brain Lower Grade Glioma	ABO	0.26	0.23	enet	10	0.26	6.0e-29	5.2	5.2	2.2e-07	0.66	0.02	0.98	FALSE
1	The Cancer Genome Atlas	Breast Invasive Carcinoma	ABO	0.07	0.08	lasso	3	0.08	5.0e-16	5.2	5.2	2.3e-07	0.63	0.02	0.98	FALSE
2	The Cancer Genome Atlas	Esophageal Carcinoma	ABO	0.27	0.13	lasso	2	0.11	1.8e-04	5.2	5.2	2.6e-07	0.63	0.01	0.97	FALSE